Interventional radiology

Shape Memory Medical Announces First Patient Treated in the EMBO-Post Market Surveillance Registry in Germany

Retrieved on: 
Wednesday, February 22, 2023
Biotechnology, Health, Surgery, Medical Devices, Radiology, Safety, Interventional radiology, Organ transplantation, Clinic, Diagnosis, Neurovascular bundle, United Kingdom, EVAR, Patient, Trial of the century, Morgan, Principal investigator, Splenomegaly, Blood, PMDA, TEVAR, Professor, CVIR, CE, Pharmaceutical industry, Medical imaging, EU

Shape Memory Medical Inc., developer of shape memory polymer for peripheral and neurovascular markets, announced the first patient treated in Germany as part of the EMBO-Post Market Surveillance Registry, the Company’s prospective, multicenter, registry study of its IMPEDE and IMPEDE-FX Embolization Plugs when used for peripheral vascular embolization.

Key Points: 
  • Shape Memory Medical Inc., developer of shape memory polymer for peripheral and neurovascular markets, announced the first patient treated in Germany as part of the EMBO-Post Market Surveillance Registry, the Company’s prospective, multicenter, registry study of its IMPEDE and IMPEDE-FX Embolization Plugs when used for peripheral vascular embolization.
  • Ted Ruppel, President and Chief Executive Officer of Shape Memory Medical Inc. said, “We would like to congratulate Professor Richter and the clinical study team at Klinikum Stuttgart for the first EMBO-PMS case in Germany.
  • “We are pleased to participate in this important study and look forward to the follow-up from our treated patients,” said Professor Richter, Principal Investigator for EMBO-Post Market Surveillance German Registry.
  • Shape Memory Medical Inc. is dedicated to developing innovative therapeutic solutions with its proprietary shape memory polymers.

Steinberg Diagnostics Celebrates 35 Years Serving Las Vegas

Retrieved on: 
Wednesday, February 22, 2023
SDMI, Mammography, Interventional radiology, Patient, Radiology, MRI, Nuclear medicine, Health, Las Vegas Valley, Dream, Multimedia, Dignity, Steinberg, PET/CT, Medical imaging, Fluoroscopy, Ultrasound

LAS VEGAS, Feb. 22, 2023 /PRNewswire/ -- In 1988 Dr. Leon Steinberg, Dr. David Steinberg, and Dr. Mark Winkler watched as the construction of the very first Steinberg Diagnostic Medical Imaging (SDMI) building was finalized.

Key Points: 
  • LAS VEGAS, Feb. 22, 2023 /PRNewswire/ -- In 1988 Dr. Leon Steinberg, Dr. David Steinberg, and Dr. Mark Winkler watched as the construction of the very first Steinberg Diagnostic Medical Imaging (SDMI) building was finalized.
  • As SDMI remembers the life of Dr. Leon Steinberg, they look back at what has grown from his dreams.
  • SDMI may have opened its doors 35 years ago, but Dr. Leon saw the potential of a dedicated outpatient radiology practice long before that.
  • On February 28, 2023, Steinberg Diagnostic Medical Imaging (SDMI) will celebrate its thirty-fifth anniversary as one of the most successful outpatient radiology providers in the Las Vegas Valley healthcare system.

Hatch Medical Retained By EndoBar Solutions To Sell Embolotherapy System, Lamina™

Retrieved on: 
Tuesday, February 21, 2023
Toxicity, Doctor of Science, Medical director, Interventional radiology, Journal of Vascular and Interventional Radiology, Journal, Therapy, L.L.C, Safety, Medicare, Acquisition, Patient, News, Pressure, ROSA, Neoplasm, Principal, DRS, Weight loss, Doctor of Philosophy, Medical device, Pharmaceutical industry, MD

SANTA ROSA BEACH, Fla., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Medical device incubator and technology brokerage firm, Hatch Medical, L.L.C.

Key Points: 
  • SANTA ROSA BEACH, Fla., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Medical device incubator and technology brokerage firm, Hatch Medical, L.L.C.
  • ( www.hatchmedical.com ) announced recently that it has been retained by EndoBar Solutions, LLC to broker a strategic transaction related to its robotic embolization system, Lamina™.
  • The embolization market is exploding and the Lamina™ system provides superior delivery,” said Steven Hvozda, Principal of Hatch Medical.
  • Nicholas Kipshidze, MD, PhD, DSc, Chief Medical Officer and Medical Director of EndoBar Solutions, L.L.C.

Mobolaji Odelowo, MD, is recognized by Continental Who's Who

Retrieved on: 
Monday, February 13, 2023
University of Ilorin, Interventional radiology, Fellow, Edema, Vertebral compression fracture, Cardiothoracic surgery, Internship, Continental, Patient, Moyamoya disease, Medical imaging, Varicose veins, University, Certification, Liver cancer, Game Developers Choice Awards, Medical degree, American Board of Commissioners for Foreign Missions, American Board of Radiology, Redeemed Christian Church of God, Multimedia, Howard University Hospital, MD, Hospital, Radiology, Angiography

CONROE, Texas, Feb. 13, 2023 /PRNewswire/ -- Mobolaji Odelowo, MD, is being recognized by Continental Who's Who as a Top Pinnacle Healthcare Provider for his contributions to Interventional Radiology and Vascular Surgery.

Key Points: 
  • CONROE, Texas, Feb. 13, 2023 /PRNewswire/ -- Mobolaji Odelowo, MD, is being recognized by Continental Who's Who as a Top Pinnacle Healthcare Provider for his contributions to Interventional Radiology and Vascular Surgery.
  • He completed an Internship and Residency in Diagnostic Radiology at Howard University Hospital, where he also served as the Chief Resident.
  • The doctor completed a Fellowship in Vascular and Interventional Radiology at the University of Pennsylvania.
  • The doctor is the Founder and Vascular Specialist at Endovascular and Interventional Associates, located in Conroe, TX.

RSNA: Photon-Counting CT Enables Lower Contrast Media for Aortic Imaging

Retrieved on: 
Thursday, January 26, 2023
Photon, Linda, Radiological Society of North America, University, Risk, Kidney, Abdomen, Diagnosis, Education, Kidney disease, Environment, Agent handling, CTA, Health, DRS, Aorta, University Hospital of Zürich, Radiation, University of Texas Southwestern Medical Center, OAK, Aneurysm, Patient, Facial muscles, Interventional radiology, Teaching hospital, Contrast agent, RSNA, Society, Iodine, Research, Medical imaging, Radiology

OAK BROOK, Ill., Jan. 26, 2023 /PRNewswire-PRWeb/ -- Photon-counting detector CT reduces the amount of contrast needed for CT angiography (CTA) while maintaining image quality, according to a new study published today, January 26, in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).

Key Points: 
  • In addition, the supply of contrast media has suffered from shortages due to COVID-19-related disruptions in the pharmaceutical supply chain.
  • Photon-counting detector CT is a new technology that can acquire high-quality images at lower contrast media volume than conventional CT scanners that rely on energy-integrating detectors.
  • Photon-counting CT had a higher contrast-to-noise ratio, a key measure of image quality, which translates to a low-volume contrast media protocol.
  • "CT Angiography of the Aorta Using Photon-counting Detector CT with Reduced Contrast Media Volume."

IceCure's ProSense Featured in Breast Session at the Society of Interventional Oncology's Annual Scientific Meeting in Washington, D.C.

Retrieved on: 
Thursday, January 26, 2023
Interventional radiology, Medical imaging, Diagnosis, CentraState Medical Center, Associate, ICE3, Breast, TASE, Interventional oncology, Flexner Report, Woman, Breast cancer, Patient, Interventions, Freezing, Alpert Medical School, Neoplasm, Assistant

(NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® System that destroys tumors by freezing, today announced its participation in the Society of Interventional Oncology's Annual Scientific Meeting (" SIO2023 ") in Washington, D.C. on January 19 - 23, 2023.

Key Points: 
  • (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® System that destroys tumors by freezing, today announced its participation in the Society of Interventional Oncology's Annual Scientific Meeting (" SIO2023 ") in Washington, D.C. on January 19 - 23, 2023.
  • ProSense was demonstrated throughout the duration of the conference at IceCure's booth.
  • Separately, in a breast session organized by SIO2023, ProSense was featured in a panel discussion on January 21st led by Dr. Kenneth Tomkovich and included Dr. Robert Ward, both ProSense users.
  • Commenting on the growing interest in ProSense, Dr. Tomkovich stated, "we are seeing increasing interest from interventional radiologists and interventional oncologists, many of whom are practitioners who previously were not treating breast cancer patients.

Modern Vascular Welcomes New Managing Physician Dr. Mamdouh Khayat

Retrieved on: 
Thursday, January 19, 2023
Publication, Clinic, Parent, Heart, Chronic limb threatening ischemia, Smoking, Death, Quality of life, Moyamoya disease, Amputation, Safety, Risk, Peripheral artery disease, CO, Plaque, Patient, Artery, Diabetes, Advocacy, PAD, Interventional radiology, Obesity, Pain, Medical imaging, Pharmaceutical industry, Hospital

Indianapolis, IN, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease (PAD), welcomes a new managing physician, Dr. Mamdouh Khayat.

Key Points: 
  • Indianapolis, IN, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease (PAD), welcomes a new managing physician, Dr. Mamdouh Khayat.
  • Dr. Khayat is a dual Board-Certified Vascular and Interventional Radiologist with particular expertise in peripheral arterial disease.
  • He taught and directed interventional radiology residency programs prior to transitioning to Modern Vascular.
  • Modern Vascular provides an online PAD quiz for patients to determine if they are a risk for PAD.

ISET celebrates 35th anniversary meeting with nearly 1,000 registrants, record-breaking number of research submissions, sold out Exhibit Hall

Retrieved on: 
Thursday, January 19, 2023
Convention, PE, National Primate Research Exhibition Hall, University of Pennsylvania, SVM, Baptist Health, SIR, MVP, Florida International University, University, Record, Interventional radiology, Division, Movement, 2021 Essex County Council election, Society for Vascular Surgery, Society, FIU Herbert Wertheim College of Medicine, SVS, Centre for the Advancement of Sustainable Medical Innovation, FACC, Faculty, HMP, Society of Interventional Radiology, Town hall, ISET, Organization, Partnership, CME, Radiology, Society for Vascular Medicine, Degenerative disease, Research, International Symposium on Endovascular Therapy, Amputation, CLI, CNE, PAD, Health, Pharmaceutical industry, Medicine, Dentistry, MD

MALVERN, Pa., Jan. 19, 2023 /PRNewswire-PRWeb/ -- For its 35th annual gathering, HMP Global's International Symposium on Endovascular Therapy (ISET) received a record-breaking amount of research submissions, welcomed nearly 1,000 registrants from around the globe, and hosted more than 40 companies in its sold-out Exhibit Hall, solidifying its position as the premier arena for pioneering and practical endovascular education.

Key Points: 
  • "From the group that pioneered live case education, ISET has grown tremendously since the first meeting 35 years ago," Katzen said.
  • "Now as the leading meeting in endovascular therapy, ISET brings together a multidisciplinary faculty and audience to discuss groundbreaking techniques, implement change, and improve patient care.
  • All abstracts underwent blind peer review for quality of research, educational or scientific content, logical presentation, and impact on healthcare.
  • Cutting-edge research e-posters were displayed on multimedia screens in the poster area of the Exhibit Hall at ISET, and late-breaking data was presented at the first major endovascular meeting in 2023.

Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

Retrieved on: 
Thursday, January 12, 2023
MedStar Health, Beaumont Health, RCT, Principal, DVT, VTE, Guy Goodwin, Hospital, MD, Isabella Tree, Patient, Allegheny Health Network, Clinical trial, Interventional radiology, St Thomas' Hospital, Medical device

The first DEFIANCE patient was enrolled by Dr. Abdullah Shaikh, Interventional Radiologist at Allegheny Health Network, Pittsburgh, PA. DEFIANCE will enroll 300 DVT patients at up to 60 centers worldwide.

Key Points: 
  • The first DEFIANCE patient was enrolled by Dr. Abdullah Shaikh, Interventional Radiologist at Allegheny Health Network, Pittsburgh, PA. DEFIANCE will enroll 300 DVT patients at up to 60 centers worldwide.
  • DEFIANCE is Inari’s second RCT, enrolling in parallel to the PEERLESS pulmonary embolism trial.
  • “We’re thrilled to enroll the first patient and officially kick off this important clinical trial,” said Dr. Shaikh.
  • “None of this is possible without the collaboration and dedication of our clinical trial investigators who continually push the field forward in the name of better patient outcomes.”

GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance

Retrieved on: 
Monday, January 9, 2023
Medical Devices, Health, Radiology, Health Technology, Medical Supplies, IGT, Hospital, MDR, Hand, Nephrology, FDA, GE, Cardiology, Shearman & Sterling, Diagnosis, Growth, Patient, Urology, Software, Medical Device Regulation Act, Interventional radiology, Oncology, Workflow, Acquisition, Intervention, GE Healthcare, European, Physician, Medical imaging, Imaging

GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire IMACTIS, an innovator in the rapidly growing field of computed tomography (CT) interventional guidance across an array of care areas.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire IMACTIS, an innovator in the rapidly growing field of computed tomography (CT) interventional guidance across an array of care areas.
  • “We’re thrilled to take this step in strengthening our interventional guidance offering for patients and customers,” said Jan Makela, President and CEO of Imaging, GE HealthCare.
  • The global Interventional Radiology market includes CT interventional guidance, and the IMACTIS acquisition provides GE HealthCare with access to this growing opportunity.
  • Shearman & Sterling LLP acted as legal advisor to GE HealthCare.